UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 15, 2023

Accession Number:	0001104659-23-059831
Submission Type:	POS AM
CIK: 0001485003 Company Name: Carisma Therapeutics Inc. File Number: 333-255943